Trimetozine-d8

• CAT Number: R053717
• CAS Number: 1346604-05-4
• Molecular Formula: C14H19NO5
• Molecular Weight: 289.357
• Purity: ≥95%
• Synonyms: 4-Morpholinyl-d8-(3,4,5-trimethoxyphenyl)methanone; NSC 62939-d8; PS 2383-d8; Opalene-d8; Sedoxazine-d8; 4-(3,4,5-Trimethoxybenzoyl)tetrahydro-1,4-oxazine-d8; Abbott 22370-d8; N-(3,4,5-Trimethoxybenzoyl)tetrahydro-1,4-oxazine-d8; Trifenoxazine-d8
• Storage: -20°C
• IUPAC Name: (2,2,3,3,5,5,6,6-octadeuteriomorpholin-4-yl)-(3,4,5-trimethoxyphenyl)methanone
• InChI: InChI=1S/C14H19NO5/c1-17-11-8-10(9-12(18-2)13(11)19-3)14(16)15-4-6-20-7-5-15/h8-9H,4-7H2,1-3H3/i4D2,5D2,6D2,7D2
• InChIKey: XWVOEFLBOSSYGM-DUSUNJSHSA-N
• SMILES: COC1=CC(=CC(=C1OC)OC)C(=O)N2CCOCC2

Trimetozine-d8 is a deuterated form of trimetozine, where eight hydrogen atoms are replaced with deuterium. Trimetozine is a medication known for its anti-anxiety and anti-depressant effects. The deuterium labeling in Trimetozine-d8 makes it useful in research for studying the drug’s pharmacokinetics, metabolism, and distribution within the body. By using techniques like mass spectrometry, researchers can precisely track and analyze the compound, gaining insights into its biological activity and potential therapeutic applications while minimizing metabolic alterations.